173 related articles for article (PubMed ID: 38463398)
1. Genome-scale CRISPR-Cas9 screen identifies
Li Y; Zhu L; Mao J; Zheng H; Hu Z; Yang S; Mao T; Zhou T; Cao P; Wu H; Wang X; Wang J; Lin F; Shen H
MedComm (2020); 2024 Mar; 5(3):e483. PubMed ID: 38463398
[TBL] [Abstract][Full Text] [Related]
2. PAICS contributes to gastric carcinogenesis and participates in DNA damage response by interacting with histone deacetylase 1/2.
Huang N; Xu C; Deng L; Li X; Bian Z; Zhang Y; Long S; Chen Y; Zhen N; Li G; Sun F
Cell Death Dis; 2020 Jul; 11(7):507. PubMed ID: 32632107
[TBL] [Abstract][Full Text] [Related]
3. Role and regulation of coordinately expressed de novo purine biosynthetic enzymes PPAT and PAICS in lung cancer.
Goswami MT; Chen G; Chakravarthi BV; Pathi SS; Anand SK; Carskadon SL; Giordano TJ; Chinnaiyan AM; Thomas DG; Palanisamy N; Beer DG; Varambally S
Oncotarget; 2015 Sep; 6(27):23445-61. PubMed ID: 26140362
[TBL] [Abstract][Full Text] [Related]
4. Expression and Role of PAICS, a De Novo Purine Biosynthetic Gene in Prostate Cancer.
Chakravarthi BV; Goswami MT; Pathi SS; Dodson M; Chandrashekar DS; Agarwal S; Nepal S; Hodigere Balasubramanya SA; Siddiqui J; Lonigro RJ; Chinnaiyan AM; Kunju LP; Palanisamy N; Varambally S
Prostate; 2017 Jan; 77(1):10-21. PubMed ID: 27550065
[TBL] [Abstract][Full Text] [Related]
5. PAICS, a Purine Nucleotide Metabolic Enzyme, is Involved in Tumor Growth and the Metastasis of Colorectal Cancer.
Agarwal S; Chakravarthi BVSK; Behring M; Kim HG; Chandrashekar DS; Gupta N; Bajpai P; Elkholy A; Balasubramanya SAH; Hardy C; Diffalha SA; Varambally S; Manne U
Cancers (Basel); 2020 Mar; 12(4):. PubMed ID: 32218208
[TBL] [Abstract][Full Text] [Related]
6. PAICS, a De Novo Purine Biosynthetic Enzyme, Is Overexpressed in Pancreatic Cancer and Is Involved in Its Progression.
Agarwal S; Chakravarthi BVSK; Kim HG; Gupta N; Hale K; Balasubramanya SAH; Oliver PG; Thomas DG; Eltoum IA; Buchsbaum DJ; Manne U; Varambally S
Transl Oncol; 2020 Jul; 13(7):100776. PubMed ID: 32422575
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of PAICS inhibits malignant proliferation of human breast cancer cell lines.
Meng M; Chen Y; Jia J; Li L; Yang S
Biol Res; 2018 Aug; 51(1):24. PubMed ID: 30097015
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of Pseudogenes/lncRNA-Hsa-miR-1-3p-PAICS Pathway Promotes the Development of NSCLC.
Song Y; Wang Z; He L; Sun F; Zhang B; Wang F
J Oncol; 2022; 2022():4714931. PubMed ID: 36081668
[TBL] [Abstract][Full Text] [Related]
9. Zebrafish mutations in gart and paics identify crucial roles for de novo purine synthesis in vertebrate pigmentation and ocular development.
Ng A; Uribe RA; Yieh L; Nuckels R; Gross JM
Development; 2009 Aug; 136(15):2601-11. PubMed ID: 19570845
[TBL] [Abstract][Full Text] [Related]
10. Generation of a Rat Monoclonal Antibody for Human PAICS, a
Yokoyama C; Bando K; Yamagata M; Nagasaki T; Tachibana T
Monoclon Antib Immunodiagn Immunother; 2024 Jun; ():. PubMed ID: 38836825
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of PAICS due to loss of chromosome 4q is associated with poor survival in stage III colorectal cancer.
Kobayashi Y; Kumamoto K; Okayama H; Matsumoto T; Nakano H; Saito K; Matsumoto Y; Endo E; Kanke Y; Watanabe Y; Onozawa H; Fujita S; Sakamoto W; Saito M; Momma T; Takenoshita S; Kono K
PLoS One; 2021; 16(2):e0247169. PubMed ID: 33596246
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide CRISPR/Cas9 screening for therapeutic targets in NSCLC carrying wild-type TP53 and receptor tyrosine kinase genes.
Wang Q; Li J; Zhu J; Mao J; Duan C; Liang X; Zhu L; Zhu M; Zhang Z; Lin F; Guo R
Clin Transl Med; 2022 Jun; 12(6):e882. PubMed ID: 35692096
[TBL] [Abstract][Full Text] [Related]
13. PAICS deficiency, a new defect of de novo purine synthesis resulting in multiple congenital anomalies and fatal outcome.
Pelet A; Skopova V; Steuerwald U; Baresova V; Zarhrate M; Plaza JM; Hnizda A; Krijt M; Souckova O; Wibrand F; Andorsdóttir G; Joensen F; Sedlak D; Bleyer AJ; Kmoch S; Lyonnet S; Zikanova M
Hum Mol Genet; 2019 Nov; 28(22):3805-3814. PubMed ID: 31600779
[TBL] [Abstract][Full Text] [Related]
14. PAICS as a potential target for cancer therapy linking purine biosynthesis to cancer progression.
Huo A; Xiong X
Life Sci; 2023 Oct; 331():122070. PubMed ID: 37673296
[TBL] [Abstract][Full Text] [Related]
15. A Role for De Novo Purine Metabolic Enzyme PAICS in Bladder Cancer Progression.
Chakravarthi BVSK; Rodriguez Pena MDC; Agarwal S; Chandrashekar DS; Hodigere Balasubramanya SA; Jabboure FJ; Matoso A; Bivalacqua TJ; Rezaei K; Chaux A; Grizzle WE; Sonpavde G; Gordetsky J; Netto GJ; Varambally S
Neoplasia; 2018 Sep; 20(9):894-904. PubMed ID: 30121007
[TBL] [Abstract][Full Text] [Related]
16. Octameric structure of the human bifunctional enzyme PAICS in purine biosynthesis.
Li SX; Tong YP; Xie XC; Wang QH; Zhou HN; Han Y; Zhang ZY; Gao W; Li SG; Zhang XC; Bi RC
J Mol Biol; 2007 Mar; 366(5):1603-14. PubMed ID: 17224163
[TBL] [Abstract][Full Text] [Related]
17. EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells.
Gong H; Li Y; Yuan Y; Li W; Zhang H; Zhang Z; Shi R; Liu M; Liu C; Chen C; Liu H; Chen J
BMC Cancer; 2020 Dec; 20(1):1189. PubMed ID: 33276757
[TBL] [Abstract][Full Text] [Related]
18. Crystal structures of human PAICS reveal substrate and product binding of an emerging cancer target.
Škerlová J; Unterlass J; Göttmann M; Marttila P; Homan E; Helleday T; Jemth AS; Stenmark P
J Biol Chem; 2020 Aug; 295(33):11656-11668. PubMed ID: 32571877
[TBL] [Abstract][Full Text] [Related]
19. Genetic and metabolomic analysis of AdeD and AdeI mutants of de novo purine biosynthesis: cellular models of de novo purine biosynthesis deficiency disorders.
Duval N; Luhrs K; Wilkinson TG; Baresova V; Skopova V; Kmoch S; Vacano GN; Zikanova M; Patterson D
Mol Genet Metab; 2013 Mar; 108(3):178-189. PubMed ID: 23394948
[TBL] [Abstract][Full Text] [Related]
20. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
[Next] [New Search]
